Whitepapers
TTR02 and PCS02 Formulation Lock
Pre-clinical Development of ALN-TTR RNAi Therapeutic for Treatment Of Transthyretin-mediated Amyloidosis Peripheral Nerve Society June 29, 2011 Transthyretin (TTR)-Mediated Amyloidosis (ATTR) Program Unmet Need and Product Opportunity RNAi to treat genetic disease ATTR is significant orphan disease
Microsoft Word - SBI Final White Paper final version for posting 6-18-11 _2_.doc
Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silicone outer shell and a filler (most commonly silicone gel..
2011 Alnylam Template
Serial measurements of Circulating TTR in Subjects with TTR Amyloidosis or Carriers of Mutant TTR Peripheral Nerve Society June 2011 Transthyretin (TTR) Amyloidosis (ATTR) Background Autosomal dominant disease Caused by extracellular deposition of mutant and wild-type TTR in target organs such as
Page:
